Taysha Gene Therapies Inc (TSHA)
EBITDA Growth
-74.30%
Quarterly · Period ending:
TSHA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-74.30%period ending
Latest reported-74.30%period ending
TSHA Quarterly EBITDA YoY % (-1542.33% → -74.30%)
Year-over-year change
High-resolution chart · PNG
TSHA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -74.2967% | |
| -98.3606% | |
| -51.6929% | |
| -28.6678% | |
| -29.1997% | |
| 10.461% | |
| -137.8103% | |
| 78.1359% | |
| 9.8006% | |
| -48.9414% | |
| 189.4746% | |
| -357.989% | |
| 31.0225% | |
| 67.7696% | |
| -10.2595% | |
| 50.1327% | |
| 18.6262% | |
| -54.3667% | |
| -170.2381% | |
| -235.6696% | |
| -91.5504% | |
| -492.0059% | |
| -1,542.3318% |